Kathrin Schumann

Reprogramming human T cell function and specificity with non-viral genome targeting

Theodore L. Roth, Cristina Puig-Saus, Ruby Yu et al. · Nature · 2018 · 853 citations · Full text

Life Sciences, Biotechnology, Immunology +16

CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells

Levi J. Rupp, Kathrin Schumann, Kole T. Roybal et al. · Scientific Reports · 2017 · 744 citations · Full text

Life Sciences, Immunology, Oncology +17

Generation of knock-in primary human T cells using Cas9 ribonucleoproteins

Kathrin Schumann, Steven Lin, Eric Boyer et al. · Proceedings of the National Academy of Sciences · 2015 · 723 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +17

Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis

Nathan D. Mathewson, Orr Ashenberg, Itay Tirosh et al. · Cell · 2021 · 403 citations · Full text

Medicine, Immunology, Oncology +11

A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors

Ryan J. Park, Dylan Koundakjian, Judd F. Hultquist et al. · Nature Genetics · 2016 · 341 citations

Life Sciences, Infectious Diseases, Molecular Biology +11